Tahir Misbah 4
4 · IGM Biosciences, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
Tahir Misbah
CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-06-16$1.20/sh−1,522$1,825→ 178,802 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.17 to $1.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price.